Phio Pharmaceuticals (PHIO) Research & Development (2016 - 2020)
Historic Research & Development for Phio Pharmaceuticals (PHIO) over the last 9 years, with Q4 2020 value amounting to $463000.0.
- Phio Pharmaceuticals' Research & Development fell 5474.1% to $463000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $3.7 million, marking a year-over-year decrease of 1358.14%. This contributed to the annual value of $7.0 million for FY2022, which is 2108.94% down from last year.
- Per Phio Pharmaceuticals' latest filing, its Research & Development stood at $463000.0 for Q4 2020, which was down 5474.1% from $1.3 million recorded in Q3 2020.
- Over the past 5 years, Phio Pharmaceuticals' Research & Development peaked at $1.5 million during Q3 2017, and registered a low of $463000.0 during Q4 2020.
- Its 5-year average for Research & Development is $1.2 million, with a median of $1.2 million in 2017.
- In the last 5 years, Phio Pharmaceuticals' Research & Development skyrocketed by 2434.37% in 2019 and then plummeted by 5474.1% in 2020.
- Over the past 5 years, Phio Pharmaceuticals' Research & Development (Quarter) stood at $1.3 million in 2016, then fell by 7.88% to $1.2 million in 2017, then decreased by 21.59% to $944000.0 in 2018, then rose by 8.37% to $1.0 million in 2019, then crashed by 54.74% to $463000.0 in 2020.
- Its Research & Development stands at $463000.0 for Q4 2020, versus $1.3 million for Q3 2020 and $779000.0 for Q2 2020.